FDA lax on medical device safety, report says

0 Shares

Report claims that FDA has poor oversight of quality standards at laboratories which develop medical devicesA non-profit organization has released a report which details the FDA’s alleged lack of oversight of quality standards at laboratories which develop medical devices.

The FDA’s Deadly Gamble with the Safety of Medical Devices report was released by the Project on Government Oversight on February 18, and singles out the Center for Devices and Radiological Health (CDRH), a part of FDA, as the main culprit.

In particular, the report alleges that senior CDRH officials have not been enforcing the Good Laboratory Practice (GLP) regulation from 1979 that prohibits manufacturers from setting their own standards of laboratory testing. As a result, manufacturers are free to monitor their own compliance with the regulation.

"There are many insiders who are deeply concerned that real harm is being done," says Danielle Brian, executive director of POGO, adding "Such a decision affecting public health should not have been made behind closed doors."

In conclusion, the organization recommends that Congress or the Department of Health and Human Services investigate the FDA officials’ decision to ignore the GLP regulation and audit records that contain evidence of manufactures’ compliance with the regulation.
ADNFCR-1961-ID-19048244-ADNFCR

Personal Liberty News Desk

Join the Discussion

Comment Policy: We encourage an open discussion with a wide range of viewpoints, even extreme ones, but we will not tolerate racism, profanity or slanderous comments toward the author(s) or comment participants. Make your case passionately, but civilly. Please don't stoop to name calling. We use filters for spam protection. If your comment does not appear, it is likely because it violates the above policy or contains links or language typical of spam. We reserve the right to remove comments at our discretion.